The global Heparin market size was valued at USD 2328.4 million in 2022 and is forecast to a readjusted size of USD 5178.6 million by 2029 with a CAGR of 12.1% during review period.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
This report is a detailed and comprehensive analysis for global Heparin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Heparin market size and forecasts, in consumption value ($ Million), sales quantity (B Units), and average selling prices (US$/B Units), 2018-2029
Global Heparin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (B Units), and average selling prices (US$/B Units), 2018-2029
Global Heparin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (B Units), and average selling prices (US$/B Units), 2018-2029
Global Heparin market shares of main players, shipments in revenue ($ Million), sales quantity (B Units), and ASP (US$/B Units), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Heparin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Heparin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical
Pfizer
Hebei Changshan Biochemical Pharmaceutical
Bioibérica
Qingdao Jiulong Biopharmaceutical
Changzhou Qianhong Biopharma
Dongying Tiandong Pharmaceutical
Opocrin
Hubei Enoray Biopharmaceutical
Yino Pharma
Cisen Pharmaceutical
Nanjing Xinbai Pharmaceutical
Sichuan Deebio Pharmaceutical
Heparin Sodium
Heparin Calcium
UFH
LMWH
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Heparin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Heparin, with price, sales, revenue and global market share of Heparin from 2018 to 2023.
Chapter 3, the Heparin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Heparin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Heparin market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Heparin.
Chapter 14 and 15, to describe Heparin sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Heparin
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Heparin Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Heparin Sodium
1.3.3 Heparin Calcium
1.4 Market Analysis by Application
1.4.1 Overview: Global Heparin Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 UFH
1.4.3 LMWH
1.5 Global Heparin Market Size & Forecast
1.5.1 Global Heparin Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Heparin Sales Quantity (2018-2029)
1.5.3 Global Heparin Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Shenzhen Hepalink Pharmaceutical
2.1.1 Shenzhen Hepalink Pharmaceutical Details
2.1.2 Shenzhen Hepalink Pharmaceutical Major Business
2.1.3 Shenzhen Hepalink Pharmaceutical Heparin Product and Services
2.1.4 Shenzhen Hepalink Pharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
2.2 Yantai Dongcheng Pharmaceutical
2.2.1 Yantai Dongcheng Pharmaceutical Details
2.2.2 Yantai Dongcheng Pharmaceutical Major Business
2.2.3 Yantai Dongcheng Pharmaceutical Heparin Product and Services
2.2.4 Yantai Dongcheng Pharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
2.3 Nanjing King-friend Biochemical Pharmaceutical
2.3.1 Nanjing King-friend Biochemical Pharmaceutical Details
2.3.2 Nanjing King-friend Biochemical Pharmaceutical Major Business
2.3.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Product and Services
2.3.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Heparin Product and Services
2.4.4 Pfizer Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments/Updates
2.5 Hebei Changshan Biochemical Pharmaceutical
2.5.1 Hebei Changshan Biochemical Pharmaceutical Details
2.5.2 Hebei Changshan Biochemical Pharmaceutical Major Business
2.5.3 Hebei Changshan Biochemical Pharmaceutical Heparin Product and Services
2.5.4 Hebei Changshan Biochemical Pharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
2.6 Bioibérica
2.6.1 Bioibérica Details
2.6.2 Bioibérica Major Business
2.6.3 Bioibérica Heparin Product and Services
2.6.4 Bioibérica Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bioibérica Recent Developments/Updates
2.7 Qingdao Jiulong Biopharmaceutical
2.7.1 Qingdao Jiulong Biopharmaceutical Details
2.7.2 Qingdao Jiulong Biopharmaceutical Major Business
2.7.3 Qingdao Jiulong Biopharmaceutical Heparin Product and Services
2.7.4 Qingdao Jiulong Biopharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
2.8 Changzhou Qianhong Biopharma
2.8.1 Changzhou Qianhong Biopharma Details
2.8.2 Changzhou Qianhong Biopharma Major Business
2.8.3 Changzhou Qianhong Biopharma Heparin Product and Services
2.8.4 Changzhou Qianhong Biopharma Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Changzhou Qianhong Biopharma Recent Developments/Updates
2.9 Dongying Tiandong Pharmaceutical
2.9.1 Dongying Tiandong Pharmaceutical Details
2.9.2 Dongying Tiandong Pharmaceutical Major Business
2.9.3 Dongying Tiandong Pharmaceutical Heparin Product and Services
2.9.4 Dongying Tiandong Pharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
2.10 Opocrin
2.10.1 Opocrin Details
2.10.2 Opocrin Major Business
2.10.3 Opocrin Heparin Product and Services
2.10.4 Opocrin Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Opocrin Recent Developments/Updates
2.11 Hubei Enoray Biopharmaceutical
2.11.1 Hubei Enoray Biopharmaceutical Details
2.11.2 Hubei Enoray Biopharmaceutical Major Business
2.11.3 Hubei Enoray Biopharmaceutical Heparin Product and Services
2.11.4 Hubei Enoray Biopharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates
2.12 Yino Pharma
2.12.1 Yino Pharma Details
2.12.2 Yino Pharma Major Business
2.12.3 Yino Pharma Heparin Product and Services
2.12.4 Yino Pharma Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Yino Pharma Recent Developments/Updates
2.13 Cisen Pharmaceutical
2.13.1 Cisen Pharmaceutical Details
2.13.2 Cisen Pharmaceutical Major Business
2.13.3 Cisen Pharmaceutical Heparin Product and Services
2.13.4 Cisen Pharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Cisen Pharmaceutical Recent Developments/Updates
2.14 Nanjing Xinbai Pharmaceutical
2.14.1 Nanjing Xinbai Pharmaceutical Details
2.14.2 Nanjing Xinbai Pharmaceutical Major Business
2.14.3 Nanjing Xinbai Pharmaceutical Heparin Product and Services
2.14.4 Nanjing Xinbai Pharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Nanjing Xinbai Pharmaceutical Recent Developments/Updates
2.15 Sichuan Deebio Pharmaceutical
2.15.1 Sichuan Deebio Pharmaceutical Details
2.15.2 Sichuan Deebio Pharmaceutical Major Business
2.15.3 Sichuan Deebio Pharmaceutical Heparin Product and Services
2.15.4 Sichuan Deebio Pharmaceutical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Sichuan Deebio Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Heparin by Manufacturer
3.1 Global Heparin Sales Quantity by Manufacturer (2018-2023)
3.2 Global Heparin Revenue by Manufacturer (2018-2023)
3.3 Global Heparin Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Heparin by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Heparin Manufacturer Market Share in 2022
3.4.2 Top 6 Heparin Manufacturer Market Share in 2022
3.5 Heparin Market: Overall Company Footprint Analysis
3.5.1 Heparin Market: Region Footprint
3.5.2 Heparin Market: Company Product Type Footprint
3.5.3 Heparin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Heparin Market Size by Region
4.1.1 Global Heparin Sales Quantity by Region (2018-2029)
4.1.2 Global Heparin Consumption Value by Region (2018-2029)
4.1.3 Global Heparin Average Price by Region (2018-2029)
4.2 North America Heparin Consumption Value (2018-2029)
4.3 Europe Heparin Consumption Value (2018-2029)
4.4 Asia-Pacific Heparin Consumption Value (2018-2029)
4.5 South America Heparin Consumption Value (2018-2029)
4.6 Middle East and Africa Heparin Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Heparin Sales Quantity by Type (2018-2029)
5.2 Global Heparin Consumption Value by Type (2018-2029)
5.3 Global Heparin Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Heparin Sales Quantity by Application (2018-2029)
6.2 Global Heparin Consumption Value by Application (2018-2029)
6.3 Global Heparin Average Price by Application (2018-2029)
7 North America
7.1 North America Heparin Sales Quantity by Type (2018-2029)
7.2 North America Heparin Sales Quantity by Application (2018-2029)
7.3 North America Heparin Market Size by Country
7.3.1 North America Heparin Sales Quantity by Country (2018-2029)
7.3.2 North America Heparin Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Heparin Sales Quantity by Type (2018-2029)
8.2 Europe Heparin Sales Quantity by Application (2018-2029)
8.3 Europe Heparin Market Size by Country
8.3.1 Europe Heparin Sales Quantity by Country (2018-2029)
8.3.2 Europe Heparin Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Heparin Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Heparin Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Heparin Market Size by Region
9.3.1 Asia-Pacific Heparin Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Heparin Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Heparin Sales Quantity by Type (2018-2029)
10.2 South America Heparin Sales Quantity by Application (2018-2029)
10.3 South America Heparin Market Size by Country
10.3.1 South America Heparin Sales Quantity by Country (2018-2029)
10.3.2 South America Heparin Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Heparin Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Heparin Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Heparin Market Size by Country
11.3.1 Middle East & Africa Heparin Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Heparin Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Heparin Market Drivers
12.2 Heparin Market Restraints
12.3 Heparin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Heparin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Heparin
13.3 Heparin Production Process
13.4 Heparin Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Heparin Typical Distributors
14.3 Heparin Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Heparin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Heparin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Shenzhen Hepalink Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Shenzhen Hepalink Pharmaceutical Major Business
Table 5. Shenzhen Hepalink Pharmaceutical Heparin Product and Services
Table 6. Shenzhen Hepalink Pharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
Table 8. Yantai Dongcheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Yantai Dongcheng Pharmaceutical Major Business
Table 10. Yantai Dongcheng Pharmaceutical Heparin Product and Services
Table 11. Yantai Dongcheng Pharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Yantai Dongcheng Pharmaceutical Recent Developments/Updates
Table 13. Nanjing King-friend Biochemical Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Nanjing King-friend Biochemical Pharmaceutical Major Business
Table 15. Nanjing King-friend Biochemical Pharmaceutical Heparin Product and Services
Table 16. Nanjing King-friend Biochemical Pharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Heparin Product and Services
Table 21. Pfizer Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Recent Developments/Updates
Table 23. Hebei Changshan Biochemical Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Hebei Changshan Biochemical Pharmaceutical Major Business
Table 25. Hebei Changshan Biochemical Pharmaceutical Heparin Product and Services
Table 26. Hebei Changshan Biochemical Pharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
Table 28. Bioibérica Basic Information, Manufacturing Base and Competitors
Table 29. Bioibérica Major Business
Table 30. Bioibérica Heparin Product and Services
Table 31. Bioibérica Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bioibérica Recent Developments/Updates
Table 33. Qingdao Jiulong Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Qingdao Jiulong Biopharmaceutical Major Business
Table 35. Qingdao Jiulong Biopharmaceutical Heparin Product and Services
Table 36. Qingdao Jiulong Biopharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
Table 38. Changzhou Qianhong Biopharma Basic Information, Manufacturing Base and Competitors
Table 39. Changzhou Qianhong Biopharma Major Business
Table 40. Changzhou Qianhong Biopharma Heparin Product and Services
Table 41. Changzhou Qianhong Biopharma Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Changzhou Qianhong Biopharma Recent Developments/Updates
Table 43. Dongying Tiandong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Dongying Tiandong Pharmaceutical Major Business
Table 45. Dongying Tiandong Pharmaceutical Heparin Product and Services
Table 46. Dongying Tiandong Pharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Dongying Tiandong Pharmaceutical Recent Developments/Updates
Table 48. Opocrin Basic Information, Manufacturing Base and Competitors
Table 49. Opocrin Major Business
Table 50. Opocrin Heparin Product and Services
Table 51. Opocrin Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Opocrin Recent Developments/Updates
Table 53. Hubei Enoray Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Hubei Enoray Biopharmaceutical Major Business
Table 55. Hubei Enoray Biopharmaceutical Heparin Product and Services
Table 56. Hubei Enoray Biopharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Hubei Enoray Biopharmaceutical Recent Developments/Updates
Table 58. Yino Pharma Basic Information, Manufacturing Base and Competitors
Table 59. Yino Pharma Major Business
Table 60. Yino Pharma Heparin Product and Services
Table 61. Yino Pharma Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Yino Pharma Recent Developments/Updates
Table 63. Cisen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Cisen Pharmaceutical Major Business
Table 65. Cisen Pharmaceutical Heparin Product and Services
Table 66. Cisen Pharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Cisen Pharmaceutical Recent Developments/Updates
Table 68. Nanjing Xinbai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Nanjing Xinbai Pharmaceutical Major Business
Table 70. Nanjing Xinbai Pharmaceutical Heparin Product and Services
Table 71. Nanjing Xinbai Pharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Nanjing Xinbai Pharmaceutical Recent Developments/Updates
Table 73. Sichuan Deebio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Sichuan Deebio Pharmaceutical Major Business
Table 75. Sichuan Deebio Pharmaceutical Heparin Product and Services
Table 76. Sichuan Deebio Pharmaceutical Heparin Sales Quantity (B Units), Average Price (US$/B Units), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Sichuan Deebio Pharmaceutical Recent Developments/Updates
Table 78. Global Heparin Sales Quantity by Manufacturer (2018-2023) & (B Units)
Table 79. Global Heparin Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Heparin Average Price by Manufacturer (2018-2023) & (US$/B Units)
Table 81. Market Position of Manufacturers in Heparin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Heparin Production Site of Key Manufacturer
Table 83. Heparin Market: Company Product Type Footprint
Table 84. Heparin Market: Company Product Application Footprint
Table 85. Heparin New Market Entrants and Barriers to Market Entry
Table 86. Heparin Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Heparin Sales Quantity by Region (2018-2023) & (B Units)
Table 88. Global Heparin Sales Quantity by Region (2024-2029) & (B Units)
Table 89. Global Heparin Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Heparin Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Heparin Average Price by Region (2018-2023) & (US$/B Units)
Table 92. Global Heparin Average Price by Region (2024-2029) & (US$/B Units)
Table 93. Global Heparin Sales Quantity by Type (2018-2023) & (B Units)
Table 94. Global Heparin Sales Quantity by Type (2024-2029) & (B Units)
Table 95. Global Heparin Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Heparin Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Heparin Average Price by Type (2018-2023) & (US$/B Units)
Table 98. Global Heparin Average Price by Type (2024-2029) & (US$/B Units)
Table 99. Global Heparin Sales Quantity by Application (2018-2023) & (B Units)
Table 100. Global Heparin Sales Quantity by Application (2024-2029) & (B Units)
Table 101. Global Heparin Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Heparin Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Heparin Average Price by Application (2018-2023) & (US$/B Units)
Table 104. Global Heparin Average Price by Application (2024-2029) & (US$/B Units)
Table 105. North America Heparin Sales Quantity by Type (2018-2023) & (B Units)
Table 106. North America Heparin Sales Quantity by Type (2024-2029) & (B Units)
Table 107. North America Heparin Sales Quantity by Application (2018-2023) & (B Units)
Table 108. North America Heparin Sales Quantity by Application (2024-2029) & (B Units)
Table 109. North America Heparin Sales Quantity by Country (2018-2023) & (B Units)
Table 110. North America Heparin Sales Quantity by Country (2024-2029) & (B Units)
Table 111. North America Heparin Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Heparin Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Heparin Sales Quantity by Type (2018-2023) & (B Units)
Table 114. Europe Heparin Sales Quantity by Type (2024-2029) & (B Units)
Table 115. Europe Heparin Sales Quantity by Application (2018-2023) & (B Units)
Table 116. Europe Heparin Sales Quantity by Application (2024-2029) & (B Units)
Table 117. Europe Heparin Sales Quantity by Country (2018-2023) & (B Units)
Table 118. Europe Heparin Sales Quantity by Country (2024-2029) & (B Units)
Table 119. Europe Heparin Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Heparin Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Heparin Sales Quantity by Type (2018-2023) & (B Units)
Table 122. Asia-Pacific Heparin Sales Quantity by Type (2024-2029) & (B Units)
Table 123. Asia-Pacific Heparin Sales Quantity by Application (2018-2023) & (B Units)
Table 124. Asia-Pacific Heparin Sales Quantity by Application (2024-2029) & (B Units)
Table 125. Asia-Pacific Heparin Sales Quantity by Region (2018-2023) & (B Units)
Table 126. Asia-Pacific Heparin Sales Quantity by Region (2024-2029) & (B Units)
Table 127. Asia-Pacific Heparin Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Heparin Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Heparin Sales Quantity by Type (2018-2023) & (B Units)
Table 130. South America Heparin Sales Quantity by Type (2024-2029) & (B Units)
Table 131. South America Heparin Sales Quantity by Application (2018-2023) & (B Units)
Table 132. South America Heparin Sales Quantity by Application (2024-2029) & (B Units)
Table 133. South America Heparin Sales Quantity by Country (2018-2023) & (B Units)
Table 134. South America Heparin Sales Quantity by Country (2024-2029) & (B Units)
Table 135. South America Heparin Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Heparin Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Heparin Sales Quantity by Type (2018-2023) & (B Units)
Table 138. Middle East & Africa Heparin Sales Quantity by Type (2024-2029) & (B Units)
Table 139. Middle East & Africa Heparin Sales Quantity by Application (2018-2023) & (B Units)
Table 140. Middle East & Africa Heparin Sales Quantity by Application (2024-2029) & (B Units)
Table 141. Middle East & Africa Heparin Sales Quantity by Region (2018-2023) & (B Units)
Table 142. Middle East & Africa Heparin Sales Quantity by Region (2024-2029) & (B Units)
Table 143. Middle East & Africa Heparin Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Heparin Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Heparin Raw Material
Table 146. Key Manufacturers of Heparin Raw Materials
Table 147. Heparin Typical Distributors
Table 148. Heparin Typical Customers
List of Figures
Figure 1. Heparin Picture
Figure 2. Global Heparin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Heparin Consumption Value Market Share by Type in 2022
Figure 4. Heparin Sodium Examples
Figure 5. Heparin Calcium Examples
Figure 6. Global Heparin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Heparin Consumption Value Market Share by Application in 2022
Figure 8. UFH Examples
Figure 9. LMWH Examples
Figure 10. Global Heparin Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Heparin Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Heparin Sales Quantity (2018-2029) & (B Units)
Figure 13. Global Heparin Average Price (2018-2029) & (US$/B Units)
Figure 14. Global Heparin Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Heparin Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Heparin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Heparin Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Heparin Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Heparin Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Heparin Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Heparin Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Heparin Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Heparin Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Heparin Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Heparin Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Heparin Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Heparin Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Heparin Average Price by Type (2018-2029) & (US$/B Units)
Figure 29. Global Heparin Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Heparin Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Heparin Average Price by Application (2018-2029) & (US$/B Units)
Figure 32. North America Heparin Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Heparin Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Heparin Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Heparin Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Heparin Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Heparin Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Heparin Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Heparin Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Heparin Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Heparin Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Heparin Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Heparin Consumption Value Market Share by Region (2018-2029)
Figure 52. China Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Heparin Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Heparin Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Heparin Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Heparin Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Heparin Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Heparin Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Heparin Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Heparin Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Heparin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Heparin Market Drivers
Figure 73. Heparin Market Restraints
Figure 74. Heparin Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Heparin in 2022
Figure 77. Manufacturing Process Analysis of Heparin
Figure 78. Heparin Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
